Background
IgA nephropathy (IgAN), the most common glomerulonephritis and the major cause of end-stage kidney disease worldwide, is characterized by the presence of IgA1 deposits in glomerular mesangial areas [
1,
2]. IgAN patients display three major alterations in IgA1: an increased level of circulating polymeric IgA1 (pIgA1), IgA containing immune complexes [
3‐
6], and under-
O-glycosylation in the hinge region [
2,
7].
The presence of abnormal
O-glycans is related to the self-aggregation of IgA1 [
8,
9]. The exposed terminal
N-acetyl-
D-galactosamine (GalNAc), resulted from under-
O-glycosylation, presents novel epitopes recognized by IgG and IgA auto-reactive antibodies [
9‐
11]. Although it has been thought that under-
O-glycosylated IgA1 can deposit in glomeruli more preferentially, the correlation between the amount of serum under-
O-glycosylated IgA1 and its glomerular deposition has not been clarified.
A lectin from
Helix aspersa (HAA), which recognizes GalNac, has been used to develop an enzyme-linked immunoadsorbent assay (HAA ELISA) for the measurement of galactose-deficient IgA1 in sera [
7]. However, the selective analysis of
O-glycans in the hinge region of pIgA1, which play an important role in the formation of immune complexes and glomerular deposition, is difficult since under-
O-glycosylated monomeric and pIgA1 are simultaneously measured by this method. We developed a novel method to quantify under-
O-glycosylated pIgA1 using a mouse Fcα/μ receptor (mFcα/μR) transfectant (pIgA1 trap). Therefore, mFcα/μR transfectants were used for the detection of human pIgA1 in the present study. Fcα/μ R is a high affinity Fc receptor for IgA and IgM. Its gene is located close to the polymeric immunoglobulin receptor (poly-IgR) on chromosome 1 [
12,
13]. Fcα/μR binds to pIgA, but not to monomeric IgA because the ligand polymerization status is crucial for the interaction of Fcα/μR [
14,
15]. Purified IgG bindings, irrespective of subclasses and aggregation, were not observed with the Fcα/μR transfectant [
16].
In this study, the correlation between serum under-O-glycosylated whole IgA1 or pIgA1 levels in IgAN patients and glomerular IgA deposition in IgAN patients was assessed.
Discussion
There was no significant correlation between data from HAA ELISA and IgA deposition area (Figure
3e). pIgA1 trap also revealed that there was no linear correlation between an aberrancy of
O-glycan in serum pIgA1 and Area-IgA (Figure
3f). We hypothesized that IgAN patients have diversified profiles of
O-glycan of serum IgA1 at the time of renal biopsy and that the patients with similar
O-glycan profiles of serum IgA1 showed similar intensities of glomerular IgA deposition.
We showed the relationships among the three parameters including Area-IgA, data from HAA ELISA, and the pIgA1 trap in two dimensions by contour plots. This graphic representation suggested that patients with specific under-
O-glycosylated profiles have similar clinical parameters including glomerular immunoglobulin and complement deposition levels and renal function. Area-IgA and serum IgA level were inversely distributed as well as Area-C3 and serum C3 level (Figure
4). It also seemed that patients with middle-level, HAA-ELISA titer values have the common characteristics of younger age, low-level IgA deposition, no IgG deposition, low C3 deposition, low urinary protein excretion, and good renal function. It seemed that these findings supported our hypothesis.
Decision tree analysis is commonly used for analysis of clinical data since it is flexible enough to express typical features of data such as nonlinearities and interactions [
23]. The patients were roughly separated into 4 groups (A, B, C, D) with the HAA ELISA titer, and Group C was further divided into two groups (C1 and C2) with the pIgA1 trap value (Figure
5a, 5b). The pIgA1 trap value of groups A, B, and D had no significant differences (Figure
5c). In the overlaid border areas of the groups on the contour plot for Area-IgA, data from ELISA and the pIgA1 trap showed that patients with a higher level of Area-IgA were located in the area of Group B (Figure
5d) and overlaid borders on the other contour plots supported the reliability of the decision tree (data not shown).
The serum pIgA1 of IgAN patients is more elevated than in healthy controls [
3] and peripheral lymphoid cells from IgAN patients synthesize significantly more pIgA1 than control subjects by pokeweed mitogen [
24]. The glomerular IgA1 deposits were mainly polymeric [
25,
26]. Clearance kinetics and renal deposition analysis of soluble IgA immune complex revealed that the clearance of monomeric IgA immune complexes was more rapid than that of pIgA1 immune complexes and only pIgA1 immune complexes deposited in glomeruli [
27]. The deglycosylated pIgA1 showed a significantly stronger binding capacity to human mesangial cells than native pIgA1, while deglycosylated mIgA did not bind to mesangial cells [
28]. IgA1-IgG or IgA1-IgA immune complex formations in serum have critical roles in the glomerular immunoglobulin deposition of IgAN. This phenomenon was derived from over-production of aberrantly galactosylated IgA1 in the serum and the generation glycan-specific IgG and IgA autoantibodies [
11,
29‐
32].
The patients in groups A and B showed IgA1 and IgG co-deposition in glomeruli, suggesting IgA1-IgG immune complex formation in serum (Table
2). The complement system was activated since C3 deposition was evident while the serum C3 level was low [
33,
34]. Circulating IgA1-IgG immune complexes are associated with the activation of the complement system [
35] and IgA1-glycan specific IgG immune complexes are elevated in IgAN patients, in addition to the levels urinary IgA1-glycan specific IgG immune complexes being correlated with proteinuria in IgAN [
11]. Moreover, these immune complexes directly stimulate glomerular mesangial cells to produce C3 [
36]. Thus, the patients in groups A and B have IgA1-IgG immune complex type IgAN with the activation of the complement system.
Table 2
Summary of decision tree analysis using HAA ELISA and pIgA1 trap
HAA ELISA titer | + | ++ | +++ | +++ | ++++ |
pIgA trap value | Middle | Middle | Middle | High | Middle |
IgA deposition area | Middle | High | Low | Low | High |
IgG deposition area | Middle | Middle | Low | Low | Low |
C3 deposition area | Middle | High | Middle | Middle | Low |
Age | Middle | Middle | High | Low | High |
Urinary protein excretion | High | High | Low | Low | Middle |
Hematuria | ++++ | ++ | +++ | + | +++ |
Serum creatinine | High | High | Middle | Low | Middle |
eGFR | Low | Low | Middle | High | Middle |
Serum IgA | Low | Middle | Low | High | High |
Serum C3 | Low | Low | Low | Low | High |
Histological grade | Middle | High | Middle | Low | High |
Patients belonging to Group C (C1 and C2) were very heterogeneous in the deposition of IgA in glomeruli, as compared with other groups (Figure
6a). The characteristics of Group C were weak IgA deposition in glomeruli without IgG depositions although a middle-range HAA ELISA titer was observed (Figure
5b,
6a). The pIgA1 trap value was elevated in Group C2. Glomerular C3 deposition was strong and the serum C3 level was in the low range in Group C, which suggests an activated complement pathway and consumption. The pIgA1 trap value was elevated in Group C2 (Table
2). According to these findings, it was suggested that an immune complex consisting of under-
O-glycosylated pIgA1 was dominant in sera in Group C2 patients. The age of the patients in Group C2 was younger than the other groups as well as having had a higher eGFR and mild histopathological finding in renal specimens (Figure
7a, d, and g).
Urinary protein excretion of group C2 became almost null three years after renal biopsy (Figure
7i) and eGFR three years after renal biopsy were higher than those at the time of renal biopsy (Figure
7j). These finding suggests that the disease activity of the patients in C2 group became calm but they were under hyperfiltration state reflecting the decrease of functional nephrons in the past. It was reported that serum IgA/C3 ratio was useful for predicting diagnosis in IgAN and positively correlates to severity of prognostic grading [
33]. The mean IgA/C3 ratio of the patients in group C2 (3.72 ± 1.29) was highest of all the grpups (A: 2.84 ± 1.2, B: 3.36 ± 0.88, C1: 2.83 ± 1.18, D: 3.06 ± 1.60) but there were no significantly difference. While the mean IgA/C3 ratio of whole our patients was 3.13 ± 1.18, that of previous report whose samples were collected from 1980 to 1999 was 4.55 ± 1.21 [
33]. Since our samples were collected in 2007 or 2008, the time of sample collection might induce decreasing IgA/C3 ratio. The decrease of IgA/C3 ratio was made by decrease of serum IgA. Mean serum IgA levels of our patients was much less than previous report (305.5 ± 127.1, 378.5 ± 106.4, respectively) [
33]. Hygienic conditions or other unknown factors changed in these two or three decades might influence the IgA production in IgAN patients. Although serum IgA/C3 ratio is still useful, it is possibly limited to adopt IgA/C3 ratio for predicting the prognosis of recent IgAN patients.
Patents in Group D showed the highest HAA ELISA titer, a middle-range pIgA1 trap value, intense glomerular IgA deposition without IgG deposition, and severe renal histopathological findings. Being older in age, middle-ranged renal function and urinary protein excretion, and elevated serum IgA concentrations were also characteristic. The elevated C3 concentration in serum and weak C3 deposition in glomeruli were especially different from the other groups (Table
2). Since glomerular IgG deposition was not observed in this group, it was suggested that the immune complex consisted of under-
O-glycosylated IgA1-glycan specific IgA immune complexes or self-aggregated under-
O-glycosylated IgA1 [
8]. Weak glomerular C3 deposition suggested that main component of this immune complex was monomeric IgA1 [
37]. Although monomeric IgA or monomeric IgA immune complexes did not deposit into glomeruli, cross-linked monomeric IgA could deposit in glomeruli [
27]. The induction of complement activation and glomerular deposition by administering cross-linked monomeric IgA was highly dependent on the nature of the antigen [
38].
Table
3 shows a summary of the speculated immune complexes deposited in glomeruli and component consumption of the patients in each group.
Table 3
Speculated form of glomerular immune complex and complements consumption
Complements | ↓ | ↓ | ↓ | ↓ | → |
Remarks | | | | Early phase? | |
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KS and YS designed study, carried out HAA ELISA and pIgA1 trap, analyzed the data, and drafted the manuscript. YS helped in collecting samples. HY and HS were trained in HAA ELISA and helped performing ELISA. YS was a leader of this study group and gave suggestions for the study design. SH also gave suggestions and assisted in data analysis and interpretation. SH, KS and AS kindly presented mouse and human Fcα/μR transfectants and wonderful suggestions. YT organized this study. All authors have read and approved the final manuscript.